2024. EVALUATION OF EFFICACY OF PROPHYLACTICALLY USED PREMEDICATION FOR THE MANAGEMENT OF NAUSEA, VOMITING AND HYPERSENSITIVITY REACTIONS TO CISPLATIN, TAXANES AND FAC (5-FLUOROURACIL, ADRIAMYCIN (DOXORUBICIN) AND CYCLOPHOSPHAMIDE) BASED CHEMOTHERAPY:. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 769–776. DOI:https://doi.org/10.53555/y6s67361.